Gender-Responsive Drug Use Treatment for Juvenile Justice Girls

描述(由申请人提供)：与没有犯罪的女性和有犯罪行为的男性相比，有犯罪行为的女孩患上药物使用障碍、精神症状和负面健康后果的风险要大得多，例如艾滋病毒/艾滋病或其他性传播感染(STI)。研究表明，女孩可能有不同的吸毒发展途径、最初的法律参与和共同出现的负面健康后果，这支持了对少年司法女孩测试针对性别的治疗的重要性。尽管最近在少年司法中更加重视针对性别的方案拟订，但缺乏经验支持的针对性别的干预措施，以改善少年司法女孩的健康、心理健康和/或法律后果。因此，这一第二阶段治疗试验的目的是在200名未被监禁的(CINI)女孩中测试预先存在的、广泛传播的性别敏感药物使用治疗(Voice)的疗效。我们试图测试声音对Cini女孩药物和酒精使用、艾滋病毒/性传播感染风险、精神症状和再犯的影响，并探索结果的调节因素和中介因素。12-18岁的CINI女孩(第一阶段干预贯通的N=6名青少年；第二阶段RCT研究的N=200名青少年)将从罗德岛家庭法院招募，并随机分为声音(积极)干预(n=100)或护理标准(控制)条件(n=100)。在第一阶段(第一年的前六个月)，将招募6名青少年完成干预和研究评估一次，以便在随机对照试验阶段之前测试随机对照试验的干预和评估程序。在第二阶段(第一年下半年至第四年)，200名青少年将被招募并在基线时随机分组，然后在治疗中期、治疗结束时以及干预后3、6、9和12个月的随访中重新评估。还将在每3个月的评估中收集青少年吸毒和性传播感染的生物标本。功效试验的结果可以用来立即改变目前广泛存在的方案执行情况，从而对少年司法女孩的基于证据的性别敏感物质使用干预措施产生直接影响。

DESCRIPTION (provided by applicant): Compared to both non-offending females and male offending counterparts, offending girls are at significantly greater risk for the development of substance use disorders, psychiatric symptoms and negative health outcomes, such as HIV/AIDS or other sexually transmitted infections (STIs). Research suggests that girls may have different developmental pathways to drug use, initial legal involvement and co-occurring negative health outcomes that support the importance of testing gender-specific treatments for juvenile justice girls. Although there is recent increased emphasis on gender-specific programming in juvenile justice, empirically supported gender specific interventions to improve health, mental health and/or legal outcomes among juvenile justice girls are lacking. The objective of this Stage II treatment trial is therefore to test the efficacy of a pre-existing, widly disseminated gender-responsive drug use treatment (VOICES) among 200 court-involved, non- incarcerated (CINI) girls. We seek to test the effect of VOICES on CINI girls' drug and alcohol use, HIV/STI risk, psychiatric symptoms and recidivism as well as explore moderators and mediators of outcomes. CINI girls, ages 12-18 (N= 6 juveniles for Phase I Intervention Run-Through; N=200 for Phase II RCT study) will be recruited from the Rhode Island Family Court and randomized to either the VOICES (active) intervention (n=100) or a Standard of Care (control) condition (n=100). In Phase I (first six months of Year 1), 6 juveniles will be recruitedto complete the Intervention Run-Through and research assessment once to allow testing of RCT intervention and assessment procedures prior to the RCT phase. In Phase II (last half of Year 1 through Year 4), 200 juveniles will be recruited and randomized at baseline and then re-assessed at mid-treatment, end of treatment, and 3, 6, 9 and 12 month post-intervention follow-ups. Biological specimens for juvenile drug use and sexually transmitted infections (STIs) will also be collected at each 3-month assessment. Efficacy trial results can be used to make immediate changes to current widespread program delivery resulting in direct impact on the field of evidence-based gender-responsive substance use interventions for juvenile justice girls.